The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study
- 1 April 2019
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 28 (8) , 2081-2090
Abstract
Quality-of-life is poor in end-stage kidney disease; however, the relationships between earlier stages of chronic kidney disease (CKD) and are poorly understood. This study explored longitudinal quality-of-life changes in a community-based CKD cohort and assessed associations between CKD and quality-of-life over time, and between baseline quality-of-life and CKD outcomes.Keywords
This publication has 29 references indexed in Scilit:
- Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF‐6D utility and mental component SF‐36 quality of life: An AusDiab analysisNephrology, 2018
- Do changes in socioeconomic factors lead to changes in mental health? Findings from three waves of a population based panel studyJournal of Epidemiology and Community Health, 2013
- Valuing SF-6D Health States Using a Discrete Choice ExperimentMedical Decision Making, 2013
- The impact of socioeconomic status on changes in the general and mental health of women over time: evidence from a longitudinal study of Australian womenInternational Journal for Equity in Health, 2013
- EQ-5D as a predictor of mortality and hospitalization in elderly peopleQuality of Life Research, 2011
- Comparison of the Prevalence and Mortality Risk of CKD in Australia Using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR Estimating Equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) StudyAmerican Journal of Kidney Diseases, 2010
- Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS)Kidney International, 2003
- Prevalence of Kidney Damage in Australian AdultsJournal of the American Society of Nephrology, 2003
- Determining Clinically Important Differences in Health Status MeasuresPharmacoEconomics, 1999
- Adaptation and Validation of the SF-36 Health Survey for Use in AustraliaJournal of Clinical Epidemiology, 1998